The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies have reported CB2 expression in certain neuronal populations, other glial cells, and by immune cells that infiltrate the CNS during inflammation”
From Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters (2025) · cites this paper as Robinson et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · cited 2×
“CB1 is highly expressed on neurons in the central nervous system (Galiegue et al. 1995; Herkenham et al. 1991; Matsuda et al. 1990) and to a lesser extent on cells of the immune system and testes (Daaka et al. 1996; Galiegue et al. 1995; Waksman et al. 1999).”
BackgroundSmad3 and NFAT cooperate to induce Foxp3 expression through its enhancer
Tone, Y., Furuuchi, K., Kojima, Y., Tykocinski, M. L., Greene, M. I., & Tone, M. (2008) · Nature Immunology · doi:10.1038/ni1549 · Cited by 807
Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
Xi, Z.-X., Peng, X.-Q., Li, X., Song, R., Zhang, H.-Y., Liu, Q.-R., Yang, H.-J., Bi, G.-H., Li, J., & Gardner, E. L. (2011) · Nature Neuroscience · doi:10.1038/nn.2874 · Cited by 397
Cencioni, M. T., Chiurchiù, V., Catanzaro, G., Borsellino, G., Bernardi, G., Battistini, L., & Maccarrone, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008688 · Cited by 235 · cited 8×
“…agonists in vivo to reduce immune mediated effects in mouse models of spinal cord injury (Adhikary et al. 2011; Baty et al. 2008), stroke (Murikinati et al. 2010; Zhang et al. 2009a, b), inflammatory bowel disease (Cencioni et al. 2010), colitis (Storr et al. 2009), and sepsis (Tschöp et al. 2009).”
InfluentialKlein, T. W., Newton, C. A., Widen, R., & Friedman, H. (1985) · Journal of Immunopharmacology · doi:10.3109/08923978509026487 · Cited by 102 · cited 1×
“It has been established that serum in cell cultures interferes with cannabinoid activity, so that there may be a poor correspondence between in vitro and in vivo doses (Klein et al. 1985; Nahas et al. 1977).”
Background
Research works printed but not linked: 74
- Adhikary S, Li H, Heller J, Skarica M, Zhang M, Ganea D, Tuma RF (2011) Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury. J Neurotrauma 28:2417–2427 · DOI
- Albert ML, Sauter B, Bhardwaj N (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86–89 · DOI · Paper page
- Al-Daccak R, Mooney N, Charron D (2004) MHC class II signaling in antigen-presenting cells. Curr Opin Immunol 16:108–113 · DOI
- Ando K, Ajchenbaum-Cymbalista F, Griffin JD (1993) Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells. Proc Natl Acad Sci U S A 90:9571–9575 · DOI · Paper page
- Arevalo-Martin A, Molina-Holgado E, Guaza C (2012) A CB1/CB2 receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin. Neuropharmacology 63:385–393 · DOI
- Basu S, Dittel BN (2011) Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease. Immunol Res 51:26–38 · DOI · Paper page
- Baty DE, Zhang M, Li H, Erb CJ, Adler MW, Ganea D, Loftus CM, Jallo JI, Tuma RF (2008) Cannabinoid CB2 receptor activation attenuates motor and autonomic function deficits in a mouse model of spinal cord injury. Clin Neurosurg 55:172–177
- Bejarano MT, de Waal MR, Abrams JS, Bigler M, Bacchetta R, de Vries JE, Roncarolo MG (1992) Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int Immunol 4:1389–1397 · DOI
- Börner C, Smida M, Hollt V, Schraven B, Kraus J (2009) Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling. J Biol Chem 284:35450–35460 · DOI
- Buckley NE, McCoy KL, Mezey E, Bonner T, Zimmer A, Felder CC, Glass M (2000) Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol 396:141–149 · DOI · Paper page
- Buller RML, Holmes KL, Hügin A, Frederickson TN, Morse HC III (1987) Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 328:77–79 · DOI · Paper page
- Candando KM, Lykken JM, Tedder TF (2014) B10 cell regulation of health and disease. Immunol Rev 259:259–272 · DOI · Paper page
- Coopman K, Smith LD, Wright KL, Ward SG (2007) Temporal variation in CB2R levels following T lymphocyte activation: Evidence that cannabinoids modulate CXCL12-induced chemotaxis. Int Immunopharmacol 7:360–371 · DOI
- Daaka Y, Friedman H, Klein TW (1996) Cannabinoid receptor proteins are increased in jurkat, human T-cell line after mitogen activation. J Pharmacol Exp Ther 276:776–783 · DOI
- Daoussis D, Andonopoulos AP, Liossis SN (2004) Targeting CD40L: a promising therapeutic approach. Clin Diagn Lab Immunol 11:635–641 · DOI
- Davidson TS, Dipaolo RJ, Anderson J, Shevach EM (2007) Cutting edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J Immunol 178:4022–4026 · DOI · Paper page
- Finn PW, Stone JR, Boothby MR, Perkins DL (2001) Inhibition of NF-kappaB-dependent T cell activation abrogates acute allograft rejection. J Immunol 167:5994–6001 · DOI
- Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O’Garra A (1991) IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444–3451 · DOI · Paper page
- Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54–61 · DOI · Paper page
- Ghosh S, Preet A, Groopman JE, Ganju RK (2006) Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes. Mol Immunol 43:2169–2179 · DOI
- Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, Uhl GR (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071:10–23 · DOI · Paper page
- Grazia TJ, Plenter RJ, Weber SM, Lepper HM, Victorino F, Zamora MR, Pietra BA, Gill RG (2010) Acute cardiac allograft rejection by directly cytotoxic CD4 T cells: parallel requirements for fas and perforin. Transplantation 89:33–39 · doi:10.1097/tp.0b013e3181be6bc7
- Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737–742 · DOI · Paper page
- Heeger PS (2003) T-cell allorecognition and transplant rejection: a summary and update. Am J Transplant 3:525–533 · DOI
- Hegde VL, Hegde S, Cravatt BF, Hofseth LJ, Nagarkatti M, Nagarkatti PS (2008) Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. Mol Pharmacol 74:20–33 · DOI
- Ho S, Clipstone N, Timmermann L, Northrop J, Graef I, Fiorentino D, Nourse J, Crabtree GR (1996) The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 80:S40–5 · DOI · Paper page
- Jose M (2007) The CARI guidelines. Calcineurin inhibitors in renal transplantation: adverse effects. Nephrology 12:S66–S74 · DOI
- Kawai T, Andrews D, Colvin RB, Sachs DH, Cosmi AB (2000) Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 6:114 · DOI · Paper page
- Kingsley CI, Karim M, Bushell AR, Wood KJ (2002) CD25 + CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 168:1080–1086 · DOI · Paper page
- Klein TW, Lane B, Newton CA, Friedman H (2000) The cannabinoid system and cytokine network. Proc Soc Exp Biol Med 225:1–8 · DOI · Paper page
- Lee RS, Grusby MJ, Glimcher LH, Winn HJ, Auchincloss H Jr (1994) Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med 179:865–872 · DOI · Paper page
- Li X, Kaminsky NE, Fischer LJ (2001) Examination of the immunosuppressive effect of Δ9-tetrahydrocannabinol in streptozotocin-induced autoimmune diabetes. Int Immunopharmacol 1:699–712 · DOI
- Li QJ, Dinner AR, Qi S, Irvine DJ, Huppa JB, Davis MM, Chakraborty AK (2004) CD4 enhances T cell sensitivity to antigen by coordinating lck accumulation at the immunological synapse. Nat Immunol 5:791–799 · DOI · Paper page
- Lu H, Kaplan BL, Ngaotepprutaram T, Kaminski NE (2009) Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol. J Leukoc Biol 85:322–329 · DOI
- Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, Ledent C, Cheng X, Carrier EJ, Mann MK, Giovannoni G, Pertwee RG, Yamamura T, Buckley NE, Hillard CJ, Lutz B, Baker D, Dittel BN (2007) Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat Med 13:492–497 · DOI · Paper page
- Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561–564 · DOI · Paper page
- Matzinger P, Bevan MJ (1977) Induction of H-2-restricted cytotoxic T cells: in vivo induction has the appearance of being unrestricted. Cell Immunol 33:92–100 · doi:10.1016/0008-8749(77)90137-x
- McKallip RJ, Nagarkatti M, Nagarkatti PS (2005) Δ9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J Immunol 174:3281–3289 · DOI · Paper page
- McMurchy AN, Bushell A, Levings MK, Wood KJ (2011) Moving to tolerance: clinical application of T regulatory cells. Semin Immunol 23:304–313 · DOI
- Miceli MC, Parnes JR (1991) The roles of CD4 and CD8 in T cell activation. Semin Immunol 3:133–141
- Mitra RS, Judge TA, Nestle FO, Turka LA, Nickoloff BJ (1995) Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. J Immunol 154:2668–2677 · DOI
- Munro S, Thomas KK, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61–65 · DOI · Paper page
- Murikinati S, Jütter E, Keinert T, Ridder DA, Muhammad S, Waibler Z, Ledent C, Zimmer A, Kalinke U, Schwaninger M (2010) Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment. FASEB J 24:788–798 · DOI
- Nagarkatti M, Rieder SA, Hegde VL, Kanada S, Nagarkatti P (2010) Do cannabinoids have a therapeutic role in transplantation? Trends Pharmacol Sci 31:345–350 · DOI
- Nahas GG, Morishima A, Desoize B (1977) Effects of cannabinoids on macromolecular synthesis and replication of cultured lymphocytes. Fed Proc 36:1748–1752
- Ngaotepprutaram T, Kaplan BL, Crawford RB, Kaminski NE (2012) Differential modulation by Δ9-tetrahydrocannabinol (Δ9-THC) of CD40 ligand (CD40L) expression in activated mouse splenic CD4+ T cells. J Neuroimmune Pharmacol 7:969–980 · DOI
- Ni X, Geller EB, Eppihimer MJ, Eisenstein TK, Adler MW, Tuma RF (2004) Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis mode. Mult Scler 10:158–164 · DOI
- Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K, Tam J, Attar-Namdar M, Kram V, Shohami E, Mechoulam R, Zimmer A, Bab I (2006) Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci U S A 103:696–701 · DOI · Paper page
- Onaivi ES, Carpio O, Ishiguro H, Schanz N, Uhl GR, Benno R (2008a) Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption. Ann N Y Acad Sci 1139:426–433 · DOI
- Onaivi ES, Ishiguro H, Gong JP, Patel S, Meozzi PA, Myers L, Perchuk A, Mora Z, Tagliaferro PA, Gardner E, Brusco A, Akinshola BE, Liu QR, Chirwa SS, Hope B, Lujilde J, Inada T, Iwasaki S, Macharia D, Teasenfitz L, Arinami T, Uhl GR (2008b) Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression. Ann N Y Acad Sci 1139:434–449 · DOI · Paper page
- Peng SL, Gerth AJ, Ranger AM, Glimcher LH (2001) NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity 14:13–20 · DOI · Paper page
- Pietra BA, Wiseman A, Bolwerk A, Rizeq M, Gill RG (2000) CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J Clin Invest 106:1003–1010 · DOI · Paper page
- Rahim RT, Meissler JJ Jr, Adler MW, Eisenstein TK (2005) Splenic macrophages and B-cells mediate immunosuppression following abrupt withdrawal from morphine. J Leukoc Biol 78:1185–1191 · DOI
- Ridge JP, Di Rosa F, Matzinger P (1998) A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393:474–478 · DOI · Paper page
- Robinson RH, Meisser JJ, Breslow-Deckman JM, Gaughan J, Adler MW, Eisenstein TK (2013) Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction. J Neuroimmune Pharmacol 8:1239–1250 · DOI
- Rosser EC, Blair PA, Mauri C (2014) Cellular targets of regulatory B cell-mediated suppression. Mol Immunol 62:296–304 · DOI
- Servettaz A, Kavian N, Nicco C, Deveaux V, Chereau C, Wang A, Zimmer A, Lotersztajn S, Weill B, Batteux F (2010) Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis. Am J Pathol 177:187–196 · DOI
- Smith SR, Terminelli C, Denhardt G (2000) Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice. J Pharmacol Exp Ther 293:136–150 · DOI · Paper page
- Storr MA, Keenan CM, Emmerdinger D, Zhang H, Yuce B, Sibaev A, Massa F, Buckley NE, Lutz B, Goke B, Brand S, Patel KD, Sharkey KA (2008) Targeting endocannabinoid degradation protects against experimental colitis in mice: Involvement of CB1 and CB2 receptors. J Mol Med 86:925–936 · DOI · Paper page
- Storr MA, Keenan CM, Zhang H, Patel KD, Makriyannis A, Sharkey KA (2009) Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis. Inflamm Bowel Dis 15:1678–1685 · DOI · Paper page
- Straus DB, Weiss A (1992) Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70:585–593 · DOI · Paper page
- Sun JB, Flach CF, Czerkinsky C, Holmgren J (2008) B lymphocytes promote expansion of regulatory T cells in oral tolerance: Powerful induction by antigen coupled to cholera toxin B subunit. J Immunol 181:8278–8287 · DOI
- Tadmor T, Zhang Y, Cho HM, Podack ER, Rosenblatt JD (2011) The absence of B lymphocytes reduces the number and function of T-regulatory cells and inhances the anti-tumor response in a murine tumor model. Cancer Immunol Immunother 60:609–319 · DOI · Paper page
- Tschöp J, Kasten KR, Nogueiras R, Goetzman HS, Cave CM, England LG, Dattilo J, Lentsch AB, Tschöp MH, Caldwell CC (2009) The cannabinoid receptor 2 is critical for the host response to sepsis. J Immunol 183:499–505 · DOI
- Ueno T, Yamada A, Ito T, Yeung MY, Gorbatov R, Shimizu T, Abdi R, Sayegh MH, Auchincloss H Jr, Najafian N (2011) Role of nuclear factor of activated T cell (NFAT) transcription factors in skin and vascularized cardiac allograft rejection. Transplantation 92:e26–7 · DOI
- van Kooten C, Banchereau J (2000) CD40-CD40 ligand. J Leukoc Biol 67:2–17 · DOI · Paper page
- Waksman Y, Olson JM, Carlisle SJ, Cabral GA (1999) The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. J Pharmacol Exp Ther 288:1357–1366 · DOI · Paper page
- Wood KJ, Bushell A, Hester J (2012) Regulatory immune cells in transplantation. Nat Rev Immunol 12:417–430 · DOI · Paper page
- Wright KL, Duncan M, Sharkey KA (2008) Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br J Pharmacol 153:263–270 · DOI · Paper page
- Xu H, Cheng CL, Chen M, Manivannan A, Cabay L, Pertwee RG, Coutts A, Forrester JV (2007) Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis. J Leukoc Biol 82:532–541 · DOI
- Zhang M, Martin BR, Adler MW, Razdan RK, Jallo JI, Tuma RF (2007) Cannabinoid CB2 receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model. J Cereb Blood Flow Metab 27:1387–1396 · DOI · Paper page
- Zhang M, Adler MW, Abood ME, Ganea D, Jallo J, Tuma RF (2009a) CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury. Microvasc Res 78:86–94 · DOI
- Zhang M, Martin BR, Adler MW, Razdan RJ, Kong W, Ganea D, Tuma RF (2009b) Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke. J Neuroimmune Pharmacol 4:249–259 · DOI
- Zhu LX, Sharma S, Stolina M, Gardner B, Roth MD, Tashkin DP, Dubinett SM (2000) Δ9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol 165:373–380 · DOI · Paper page
Cited by
The CB2 receptor and its role as a regulator of inflammation
Turcotte, C., Blanchet, M.-R., Laviolette, M., & Flamand, N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2300-4 · Cited by 588
Laloli, K. J., Rentsch, P., Stayte, S., & Vissel, B. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1682979 · Cited by 3
Metadata
- Authors
- Robinson, R. H., Meissler, J. J., Fan, X., Yu, D., Adler, M. W., & Eisenstein, T. K.
- Venue
- Journal of Neuroimmune Pharmacology
- Published
- 2015-05-16
- Volume
- 10
- Issue
- 2
- Pages
- 318-332
- ISSN
- 1557-1890
- 1557-1904
- Cited by
- 46
- References
- 5
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10. https://app.cochat.ai/papers/10.1007/s11481-015-9611-3
- The paper
- Robinson, R. H., Meissler, J. J., Fan, X., Yu, D., Adler, M. W., & Eisenstein, T. K. (2015). A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10. Journal of Neuroimmune Pharmacology. https://doi.org/10.1007/s11481-015-9611-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.